Literature DB >> 26933575

Vestibular Deficits Following Concussion.

J Gordon Millichap1.   

Abstract

Investigators from the Division of Emergency Medicine, Sports Medicine, and Department of Pediatrics, Children's Hospital of Philadelphia, PA, and Sports Medicine, Somerset, NJ, performed a retrospective cohort study of 247 patients ages 5-18 years with concussion referred from July 2010 to Dec 2011; 81% of patients showed a vestibular abnormality on initial clinical examination.

Entities:  

Keywords:  Cognitive Testing; Concussion; Pediatric; Vestibular Deficits

Year:  2015        PMID: 26933575      PMCID: PMC4747272          DOI: 10.15844/pedneurbriefs-29-5-2

Source DB:  PubMed          Journal:  Pediatr Neurol Briefs        ISSN: 1043-3155


Investigators from the Division of Emergency Medicine, Sports Medicine, and Department of Pediatrics, Children's Hospital of Philadelphia, PA, and Sports Medicine, Somerset, NJ, performed a retrospective cohort study of 247 patients ages 5-18 years with concussion referred from July 2010 to Dec 2011; 81% of patients showed a vestibular abnormality on initial clinical examination. The Vestibular/Ocular Motor screening assessment includes tests for dysmetria, nystagmus, smooth pursuits, fast saccades, and gaze stability, near-point convergence, and gait/balance testing. Vestibular deficits included either abnormal vestibular ocular reflex (VOR) or abnormal tandem gait testing. Patients with vestibular clinical signs initially took a significantly longer time to return to school (median 59 days vs 6 days, P=.001) or to be fully cleared (median 106 days vs 29 days, P=.001). They scored more poorly on initial neurocognitive testing and they took longer to recover from neurocognitive deficits. Patients with 3 or more previous concussions had a greater prevalence of vestibular deficits, and it took longer for those deficits to resolve. Vestibular rehabilitation therapy is recommended. [1] COMMENTARY. While vestibular deficits as symptoms of concussion are well recognized [2], the correlation of persistent signs of vestibular dysfunction with extended recovery times and neurocognitive deficits are not previously reported. Vestibular dysfunction is a prevalent sequel to sports and recreation-related concussions in children and adolescents, and vestibular rehabilitation is important in their management. Since recovery is often slow and prolonged, causes of vertigo and ataxia other than trauma may need to be considered in diagnosis and treatment. These include infection (otomastoiditis, labyrinthitis, vestibular neuritis, herpes zoster oticus), vertebrobasilar insufficiency, and benign paroxysmal positional vertigo. The injury to the vestibular system may be central (vestibular nuclei and cerebellum) or peripheral (semicircular canals, otoliths, vestibular nerve). The location of the injury may lead to a specific form of therapy. Vestibular paroxysmia is a rare but treatable cause of short vertigo attacks related to arterial compression of the eighth cranial nerve. Usually found in adults, a report of three pediatric cases, ages 8, 9, and 12 years, is noteworthy. Brief, vertiginous attacks with nystagmus occurred several times a day. MRI revealed arterial compression of the vestibular nerve. Attacks were controlled by low-dose carbamazepine (2-4 mg/kg daily) [3].
  3 in total

1.  Vestibular paroxysmia in children: a treatable cause of short vertigo attacks.

Authors:  Nadine Lehnen; Thyra Langhagen; Florian Heinen; Doreen Huppert; Thomas Brandt; Klaus Jahn
Journal:  Dev Med Child Neurol       Date:  2014-08-22       Impact factor: 5.449

2.  Vestibular Deficits following Youth Concussion.

Authors:  Daniel J Corwin; Douglas J Wiebe; Mark R Zonfrillo; Matthew F Grady; Roni L Robinson; Arlene M Goodman; Christina L Master
Journal:  J Pediatr       Date:  2015-03-05       Impact factor: 4.406

Review 3.  Vestibular rehabilitation after mild traumatic brain injury with vestibular pathology.

Authors:  Kim Gottshall
Journal:  NeuroRehabilitation       Date:  2011       Impact factor: 2.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.